Control Print Limited
Our verdict
Valuation (86/100) does the heavy lifting; financial trend (25/100) is the drag.
Our fair value
Undervalued by 29%Buy-below (20% margin of safety): ₹646.1
Our blended model reads Control Print Limited as a Buy at 62/100. We put fair value near ₹807.62; at ₹624.3 that leaves roughly 29% upside, so the stock screens undervalued by 29%. On 24.2x trailing earnings it sits cheaper than the Industrials median of about 29.0x. The price is about 17% below its 52-week high of ₹756.64 and 20% above the low of ₹519.63. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 8 of 13 investability checks, with durability 55, valuation 72 and momentum 71 on our 0–100 scales.
Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹646.1.
1-year price
EOD · 2026-11-2052-week range
-17.49% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Buy62Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 10.1%
- Pass: Low debt (D/E < 0.5): 0.02x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 14%
- Fail: Earnings growing: -83%
- Fail: Net margin ≥ 10%: 9.0%
- Pass: Current ratio > 1.5: 3.26
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 6.4
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter59.3%
- Institutions1.7%
- Public & other39.0%
Promoter holding via insider stake; institutional via reported holdings.
Superstar investors in Control Print Limited
Named in the company's June 2026 shareholding filing with the exchanges.
All superstar portfolios →Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 6.4.
Opportunities
- Revenue growing (14% YoY).
- Trading in our value buy zone versus sector peers.
- Trades ~29% below our estimated fair value.
Bear case
Threats
- Earnings contracting year on year.
About Control Print Limited
Control Print Limited manufactures and sells coding and marking machines, including continuous inkjet, thermal inkjet, high-resolution, thermal transfer, laser, and large character printers, along with related consumables such as inkjet fluids, ribbons, and ink rolls. The company also produces surgical face masks and respiratory protection products including N95 and FFP2 masks. It operates in India and internationally.
Control Print Limited — frequently asked questions
Is Control Print Limited a buy, hold or sell?
TickerMagic currently rates Control Print Limited (CONTROLPR) a Buy, based on a blended score of 62/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Control Print Limited's fair value?
Our blended DCF and relative-valuation model estimates Control Print Limited's fair value at about ₹807.62, versus a current price of ₹624.3 — roughly 29% upside. On that basis the stock looks undervalued by 29%.
Is Control Print Limited financially healthy?
Control Print Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Control Print Limited's share price performed?
Control Print Limited is up 9% over three months, and last traded at ₹624.3. Past performance doesn't predict future returns.
More in Industrials
Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.